Refreshing results…
A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis
Download from doi.orgSecond primary malignancy in myelofibrosis patients treated with ruxolitinib
UploadBrentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma
Download from doi.orgMissing publications? Search for publications with a matching author name.